La Jolla Institute for Immunology May 7 2026 Scientists at La Jolla Institute for Immunology (LJI) are the first in the world to characterize human antibodies capable of neutralizing measles virus. These antibodies bind to key sites on measles virus and prevent the virus from entering host cells. The new panel of human antibodies may form the basis for future medical therapies against measles infection. In the study, an infusion of these antibodies resulted in a 500-fold lower viral load in a